Cipla Limited — JV/Acquisition, 03-11-2025: Acquisition

Cipla has fully acquired Inzpera Healthsciences Limited, buying a 100% stake for approximately ₹110.65 Cr. Inzpera specializes in pediatric pharmaceutical and wellness products. This strategic move significantly strengthens Cipla's product portfolio and expands its reach in the high-growth children's health segment. The acquisition aims to leverage Cipla's robust distribution network and operational scale, driving substantial growth and market penetration for its combined offerings in India.